BioHarvest Sciences Inc. - Common Stock (NQ:BHST)

1.660 +0.160 (+10.67%)

Delayed Quote Updated: 4:00 PM EDT, Oct 9, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about BioHarvest Sciences Inc. - Common Stock

BioHarvest Sciences (BHST) Q2 2026 Earnings Call Transcript ↗

August 11, 2026

Rakib outlines shift toward CDMO and secures $20M-$30M fragrance contract.

Via The Motley Fool

Topics Earnings

BioHarvest Sciences Q2 Earnings Call Highlights ↗

August 11, 2026

BioHarvest Sciences (NASDAQ:BHST) reported second-quarter 2026 revenue of $8.8 million, up 3.8% from $8.5 million a year earlier, while highlighting its first manufacturing and supply agreement within...

Via MarketBeat

Topics Earnings

BioHarvest (BHST) Q4 2025 Earnings Transcript ↗

May 27, 2026

BioHarvest (BHST) Q4 2025 Earnings Transcript

Via The Motley Fool

Earnings Scheduled For November 13, 2025 ↗

November 13, 2025

Via Benzinga

BioHarvest (BHST) Q1 2026 Earnings Transcript ↗

May 18, 2026

BioHarvest (BHST) Q1 2026 Earnings Transcript

Via The Motley Fool

BioHarvest Sciences Q1 Earnings Call Highlights ↗

May 14, 2026

BioHarvest Sciences (NASDAQ:BHST) reported higher first-quarter revenue and reiterated its 2026 outlook as management detailed a broader reorganization around two business lines: its direct-to-consumer...

Via MarketBeat

Topics Earnings

BioHarvest Sciences Inc. - Common Stock Earnings Preview ↗

November 12, 2025

Via Benzinga

EXCLUSIVE: Botanical Synthesis Tech-Focused BioHarvest's First Synthetic Olive Cells Shows Reduced Fat Accumulation in Liver Cells ↗

March 04, 2025

BioHarvest's olive cell compound, rich in Verbascoside, showed promising results in reducing fat accumulation in liver cells, with a 2026 market launch planned.

Via Benzinga

Earnings Scheduled For August 11, 2025 ↗

August 11, 2025

Via Benzinga

Earnings Scheduled For May 15, 2025 ↗

May 15, 2025

Via Benzinga

Earnings Scheduled For March 31, 2025 ↗

March 31, 2025

Via Benzinga

EXCLUSIVE: BioHarvest Collaborate With Tate & Lyle To Develop Proprietary Plant-Based Molecules ↗

December 11, 2024

Tate & Lyle and BioHarvest Sciences partner to develop sustainable and affordable plant-based molecules for food and beverage industry.

Via Benzinga

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.